EDITAS MEDICINE, INC. Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent
EDITAS MEDICINE, INC. (EDIT) reported Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent of 0.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate · last filed 2026-03-09
- EDITAS MEDICINE, INC. effective income tax rate reconciliation, change in enacted tax rate, percent for fiscal 2025 was 0.00%.
- EDITAS MEDICINE, INC. effective income tax rate reconciliation, change in enacted tax rate, percent for fiscal 2024 was 0.00%.
- EDITAS MEDICINE, INC. effective income tax rate reconciliation, change in enacted tax rate, percent for fiscal 2023 was -4.50%.
- EDITAS MEDICINE, INC. effective income tax rate reconciliation, change in enacted tax rate, percent for fiscal 2022 was -3.30%, a 165.61% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent 12 month | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | 0.00% 10-K · filed 2026-03-09 | |
| 2024-12-31 | 0.00% 10-K · filed 2026-03-09 | -2.60% 10-K · filed 2025-03-05 |
| 2023-12-31 | -4.50% 10-K · filed 2025-03-05 | |
| 2022-12-31 | -3.30% 10-K · filed 2024-02-28 | -3.26% 10-K · filed 2023-02-22 |
| 2021-12-31 | 5.03% 10-K · filed 2023-02-22 | |
| 2017-12-31 | -24.70% 10-K · filed 2020-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |